A multi-ancestry genome-wide study incorporating gene-smoking interactions identifies multiple new loci for pulse pressure and mean arterial pressure

Imagem de Miniatura
Arquivos
art_SUNG_A_multiancestry_genomewide_study_incorporating_genesmoking_interactions_identifies_2019.PDF (7.5 MB)
Citações na Scopus
24
Tipo de produção
article
Data de publicação
2019
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
OXFORD UNIV PRESS
Autores
SUNG, Yun Ju
FUENTES, Lisa de Las
WINKLER, Thomas W.
I, Daniel Chasman
BENTLEY, Amy R.
KRAJA, Aldi T.
NTALLA, Ioanna
WARREN, Helen R.
GUO, Xiuqing
SCHWANDER, Karen
Citação
HUMAN MOLECULAR GENETICS, v.28, n.15, p.2615-2633, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Elevated blood pressure (BP), a leading cause of global morbidity and mortality, is influenced by both genetic and lifestyle factors. Cigarette smoking is one such lifestyle factor. Across five ancestries, we performed a genome-wide gene-smoking interaction study of mean arterial pressure (MAP) and pulse pressure (PP) in 129 913 individuals in stage 1 and follow-up analysis in 480 178 additional individuals in stage 2. We report here 136 loci significantly associated with MAP and/or PP. Of these, 61 were previously published through main-effect analysis of BP traits, 37 were recently reported by us for systolic BP and/or diastolic BP through gene-smoking interaction analysis and 38 were newly identified (P < 5 x 10(-8), false discovery rate < 0.05). We also identified nine new signals near known loci. Of the 136 loci, 8 showed significant interaction with smoking status. They include CSMD1 previously reported for insulin resistance and BP in the spontaneously hypertensive rats. Many of the 38 new loci show biologic plausibility for a role in BP regulation. SLC26A7 encodes a chloride/bicarbonate exchanger expressed in the renal outer medullary collecting duct. AVPR1A is widely expressed, including in vascular smooth muscle cells, kidney, myocardium and brain. FHAD1 is a long non-coding RNA overexpressed in heart failure. TMEM51 was associated with contractile function in cardiomyocytes. CASP9 plays a central role in cardiomyocyte apoptosis. Identified only in African ancestry were 30 novel loci. Our findings highlight the value of multi-ancestry investigations, particularly in studies of interaction with lifestyle factors, where genomic and lifestyle differences may contribute to novel findings.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/34355
Referências
  1. Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534
  2. Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632
  3. Aoyagi T, 2008, AM J PHYSIOL-RENAL, V295, pF100, DOI 10.1152/ajprenal.00088.2008
  4. Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110
  5. Armando I, 2007, HYPERTENSION, V49, P672, DOI 10.1161/01.HYP.0000254486.00883.3d
  6. Aschard H, 2010, HUM HERED, V70, P292, DOI 10.1159/000323318
  7. Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134
  8. Begum N, 2011, J BIOL CHEM, V286, P26238, DOI 10.1074/jbc.M110.214155
  9. BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
  10. Bentley AR, 2019, NAT GENET, V51, P636, DOI 10.1038/s41588-019-0378-y
  11. Blacher J, 2000, ARCH INTERN MED, V160, P1085, DOI 10.1001/archinte.160.8.1085
  12. Blacher J, 2005, NAT CLIN PRACT CARD, V2, P450, DOI 10.1038/ncpcardio0307
  13. BURRELL LM, 1995, HYPERTENSION, V26, P828, DOI 10.1161/01.HYP.26.5.828
  14. Cingolani OH, 2011, CIRC RES, V109, P1410, DOI 10.1161/CIRCRESAHA.111.256743
  15. Coan PM, 2017, DIS MODEL MECH, V10, P297, DOI 10.1242/dmm.026716
  16. Dart AM, 2001, J AM COLL CARDIOL, V37, P975, DOI 10.1016/S0735-1097(01)01108-1
  17. Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025
  18. Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052
  19. Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x
  20. di Salvo TG, 2015, J CARD FAIL, V21, P398, DOI 10.1016/j.cardfail.2015.02.005
  21. Duan P, 2015, J HUM HYPERTENS, V29, P749, DOI 10.1038/jhh.2015.13
  22. Ehret GB, 2016, NAT GENET, V48, P1171, DOI 10.1038/ng.3667
  23. Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405
  24. Elliott HR, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-4
  25. Evangelou E, 2018, NAT GENET, V50, P1412, DOI 10.1038/s41588-018-0205-x
  26. Fontana V, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001398
  27. Franklin SS, 1999, CIRCULATION, V100, P354, DOI 10.1161/01.CIR.100.4.354
  28. Franklin SS, 1997, CIRCULATION, V96, P308
  29. Gambier N, 2006, J HYPERTENS, V24, P2199, DOI 10.1097/01.hjh.0000249697.26983.aa
  30. Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190
  31. Gasowski J, 2002, J HYPERTENS, V20, P145, DOI 10.1097/00004872-200201000-00021
  32. Giri A, 2019, NAT GENET, V51, P51, DOI 10.1038/s41588-018-0303-9
  33. GOLDBERG LI, 1972, PHARMACOL REV, V24, P1
  34. Han YC, 2006, CIRC RES, V99, P415, DOI 10.1161/01.RES.0000237387.05259.a5
  35. Henke N, 2007, CIRC RES, V101, P268, DOI 10.1161/CIRCRESAHA.107.150474
  36. Hes FJ, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-92
  37. Hoffmann TJ, 2017, NAT GENET, V49, P54, DOI 10.1038/ng.3715
  38. Hong KW, 2010, J HUM HYPERTENS, V24, P367, DOI 10.1038/jhh.2009.86
  39. Irvin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024052
  40. Joehanes R, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1142-6
  41. Keller MC, 2014, BIOL PSYCHIAT, V75, P18, DOI 10.1016/j.biopsych.2013.09.006
  42. King KS, 2014, MOL CELL ENDOCRINOL, V386, P92, DOI 10.1016/j.mce.2013.07.032
  43. Kirk E.P., 2017, CIRC-CARDIOVASC GENE, V10, P1
  44. Koriyama H, 2010, J ATHEROSCLER THROMB, V17, P1054, DOI 10.5551/jat.4291
  45. Koshimizu T, 2006, P NATL ACAD SCI USA, V103, P7807, DOI 10.1073/pnas.0600875103
  46. Kraft P, 2007, HUM HERED, V63, P111, DOI 10.1159/000099183
  47. Kutalik Z, 2011, GENET EPIDEMIOL, V35, P341, DOI 10.1002/gepi.20582
  48. Kuzmenko YS, 1998, FEBS LETT, V434, P183, DOI 10.1016/S0014-5793(98)00977-6
  49. Lao Y, 2014, CELL BIOL TOXICOL, V30, P147, DOI 10.1007/s10565-014-9276-3
  50. Lee BY, 2017, ANN REHABIL MED-ARM, V41, P197, DOI 10.5535/arm.2017.41.2.197
  51. Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384
  52. Lewington S, 2002, LANCET, V360, P1903
  53. Li XX, 2001, HYPERTENSION, V38, P303, DOI 10.1161/01.HYP.38.3.303
  54. Liu CT, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003681
  55. Liu CY, 2016, NAT GENET, V48, P1162, DOI 10.1038/ng.3660
  56. Luecke S, 2010, PIGM CELL MELANOMA R, V23, P828, DOI 10.1111/j.1755-148X.2010.00762.x
  57. Lund AK, 2006, TOXICOL APPL PHARM, V212, P127, DOI 10.1016/j.taap.2005.07.005
  58. Luo F, 2009, HYPERTENSION, V54, P796, DOI 10.1161/HYPERTENSIONAHA.109.135103
  59. Maass PG, 2015, NAT GENET, V47, P647, DOI 10.1038/ng.3302
  60. MANN SJ, 1991, JAMA-J AM MED ASSOC, V265, P2226, DOI 10.1001/jama.265.17.2226
  61. Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274
  62. Manning AK, 2011, GENET EPIDEMIOL, V35, P11, DOI 10.1002/gepi.20546
  63. Markunas CA, 2014, ENVIRON HEALTH PERSP, V122, P1147, DOI 10.1289/ehp.1307892
  64. Martey CA, 2005, AM J PHYSIOL-LUNG C, V289, pL391, DOI 10.1152/ajplung.00062.2005
  65. McDonough CW, 2013, J HYPERTENS, V31, P698, DOI 10.1097/HJH.0b013e32835e2a71
  66. Millar JA, 1999, J HYPERTENS, V17, P1065, DOI 10.1097/00004872-199917080-00004
  67. Moon Sanghoon, 2011, Genomics & Informatics, V9, P152, DOI 10.5808/GI.2011.9.4.152
  68. Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361
  69. Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965
  70. Niermann T, 2003, BIOCHEM BIOPH RES CO, V300, P943, DOI 10.1016/S0006-291X(02)02970-4
  71. Org E, 2009, HUM MOL GENET, V18, P2288, DOI 10.1093/hmg/ddp135
  72. OUIMET CC, 1989, J NEUROSCI, V9, P865
  73. Paisan-Ruiz C, 2010, MOVEMENT DISORD, V25, P1791, DOI 10.1002/mds.23221
  74. Parmar PG, 2016, CIRC-CARDIOVASC GENE, V9, P266, DOI 10.1161/CIRCGENETICS.115.001190
  75. Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890
  76. Petrovic S, 2004, AM J PHYSIOL-RENAL, V286, pF161, DOI 10.1152/ajprenal.00219.2003
  77. Pierce GL, 2009, CIRCULATION, V119, P1284, DOI 10.1161/CIRCULATIONAHA.108.804294
  78. Pierce RC, 2006, NEUROSCI BIOBEHAV R, V30, P215, DOI 10.1016/j.neubiorev.2005.04.016
  79. Primatesta P, 2001, HYPERTENSION, V37, P187, DOI 10.1161/01.HYP.37.2.187
  80. Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500
  81. Rao DC, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.116.001649
  82. Ronzaud C, 2013, J CLIN INVEST, V123, P657, DOI 10.1172/JCI61110
  83. Sesso HD, 2000, HYPERTENSION, V36, P801, DOI 10.1161/01.HYP.36.5.801
  84. Simino Jeannette, 2013, Frontiers in Genetics, V4, P277, DOI 10.3389/fgene.2013.00277
  85. Sung YJ, 2018, AM J HUM GENET, V102, P375, DOI 10.1016/j.ajhg.2018.01.015
  86. Sung YJ, 2016, GENET EPIDEMIOL, V40, P404, DOI 10.1002/gepi.21978
  87. Surendran P, 2016, NAT GENET, V48, P1151, DOI 10.1038/ng.3654
  88. Svensson-Farbom P, 2011, J HYPERTENS, V29, P388, DOI 10.1097/HJH.0b013e3283410390
  89. Tchetgen EJT, 2011, EPIDEMIOLOGY, V22, P257, DOI 10.1097/EDE.0b013e31820877c5
  90. Toka O, 2015, HYPERTENSION, V66, P800, DOI 10.1161/HYPERTENSIONAHA.115.06000
  91. Tyrrell J, 2017, INT J EPIDEMIOL, V46, P559, DOI 10.1093/ije/dyw337
  92. Uhl GR, 2008, ANN NY ACAD SCI, V1141, P318, DOI 10.1196/annals.1441.018
  93. Vasan RS, 2009, JAMA-J AM MED ASSOC, V302, P168, DOI 10.1001/jama.2009.978-a
  94. Voorman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019416
  95. Wang L, 2014, AM J HYPERTENS, V27, P1387, DOI 10.1093/ajh/hpu049
  96. Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917
  97. Warren HR, 2017, NAT GENET, V49, P1558, DOI [10.1038/ng.3768, 10.1038/ng1017-1558a]
  98. WHELTON PK, 2017, HYPERTENSION, DOI [DOI 10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000065]
  99. Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340
  100. Winkler TW, 2015, BIOINFORMATICS, V31, P259, DOI 10.1093/bioinformatics/btu621
  101. Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071
  102. WOODS RL, 1983, AM J PHYSIOL, V245, pF615
  103. Yang Y, 2014, HYPERTENSION, V64, P825, DOI 10.1161/HYPERTENSIONAHA.114.03840
  104. ZEILEIS A., 2006, J STAT SOFTW, V16, P1, DOI 10.18637/JSS.V016.I09
  105. Zhang YR, 2016, AM J PHYSIOL-RENAL, V310, pF128, DOI 10.1152/ajprenal.00453.2014
  106. Zheng X, 2011, AM J HYPERTENS, V24, P145, DOI 10.1038/ajh.2010.222
  107. Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/13
Artigos e Materiais de Revistas Científicas - ODS/03